Resotran (REH-zo-tran), a new GI motility agent for chronic constipation

Women will be trying Resotran (REH-zo-tran), a new GI motility agent for chronic constipation.

Think of it as a safer version of cisapride (Prepulsid) or tegaserod (Zelnorm). These were taken off the market due to cardiac toxicity.

Resotran (prucalopride) is more selective for 5-HT4 serotonin receptors in the GI tract that stimulate motility.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote